SCHEMBL20122454

SCHEMBL20122454

CC(C)(SC(=O)c1cccs1)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.45
▸ ADAM17 P78536 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ MME P08473 1/20 0.41
▸ ACE P12821 1/20 0.41
▸ ACE2 Q9BYF1 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ FNTA P49354 2/20 0.38
▸ FNTB P49356 2/20 0.38
▸ PGGT1B P53609 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ PTGS2 P35354 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122473 0.88 MAPT (0.46) MAPTADAM17KMT2AATMMME
SCHEMBL20122512 0.79 MAPT (0.34) MAPTADAM17KMT2AATMTSHR
SCHEMBL20122511 0.79 MAPT (0.34) MAPTADAM17KMT2AATMMME
SCHEMBL20122510 0.77 HPGD (0.40) MAPTADAM17KMT2AATMNFKB1
SCHEMBL20122460 0.77 ACE (0.51) MAPTADAM17KMT2AATMMME
SCHEMBL20122456 0.77 ACE (0.40) MAPTKMT2AMMEACEACE2
SCHEMBL11188353 0.77 ELANE (0.55) MAPTADAM17KMT2AATMMME
SCHEMBL11188356 0.77 ELANE (0.55) MAPTADAM17KMT2AATMMME
SCHEMBL9705400 0.76 RAB9A (0.54) KMT2ATSHRKDM4ESMN1; SMN2HPGD
SCHEMBL9705401 0.76 RAB9A (0.54) KMT2ATSHRKDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback